Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
AAAS Promotion

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 16 April 1999:
Vol. 284. no. 5413, pp. 455 - 461
DOI: 10.1126/science.284.5413.455
Prev | Table of Contents | Next

Research Articles

Structure of the VHL-ElonginC-ElonginB Complex: Implications for VHL Tumor Suppressor Function

Charles E. Stebbins, 1 William G. Kaelin Jr., 2 Nikola P. Pavletich 3*

Mutation of the VHL tumor suppressor is associated with the inherited von Hippel-Lindau (VHL) cancer syndrome and the majority of kidney cancers. VHL binds the ElonginC-ElonginB complex and regulates levels of hypoxia-inducible proteins. The structure of the ternary complex at 2.7 angstrom resolution shows two interfaces, one between VHL and ElonginC and another between ElonginC and ElonginB. Tumorigenic mutations frequently occur in a 35-residue domain of VHL responsible for ElonginC binding. A mutational patch on a separate domain of VHL indicates a second macromolecular binding site. The structure extends the similarities to the SCF (Skp1-Cul1-F-box protein) complex that targets proteins for degradation, supporting the hypothesis that VHL may function in an analogous pathway.

1 Department of Biochemistry and Structural Biology, Joan and Sanford I. Weill Graduate School of Medical Sciences, Cornell University, New York, NY 10021, USA.
2 Dana-Farber Cancer Institute and Howard Hughes Medical Institute, Harvard Medical School, Boston, MA 02115, USA.
3 Cellular Biochemistry and Biophysics Program and Howard Hughes Medical Institute, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.
*   To whom correspondence should be addressed.

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Hypoxia-mediated Na-K-ATPase degradation requires von Hippel Lindau protein.
G. Zhou, L. A. Dada, N. S. Chandel, K. Iwai, E. Lecuona, A. Ciechanover, and J. I. Sznajder (2008)
FASEB J 22, 1335-1342
   Abstract »    Full Text »    PDF »
Itch-/-{alpha}{beta} and {gamma}{delta} T cells independently contribute to autoimmunity in Itchy mice.
V. Parravicini, A.-C. Field, P. D. Tomlinson, M. Albert Basson, and R. Zamoyska (2008)
Blood 111, 4273-7282
   Abstract »    Full Text »    PDF »
Characterization of Cullin-box Sequences That Direct Recruitment of Cul2-Rbx1 and Cul5-Rbx2 Modules to Elongin BC-based Ubiquitin Ligases.
N. Mahrour, W. B. Redwine, L. Florens, S. K. Swanson, S. Martin-Brown, W. D. Bradford, K. Staehling-Hampton, M. P. Washburn, R. C. Conaway, and J. W. Conaway (2008)
J. Biol. Chem. 283, 8005-8013
   Abstract »    Full Text »    PDF »
Allosteric effects in the marginally stable von Hippel-Lindau tumor suppressor protein and allostery-based rescue mutant design.
J. Liu and R. Nussinov (2008)
PNAS 105, 901-906
   Abstract »    Full Text »    PDF »
Characterization of Arabidopsis and Rice DWD Proteins and Their Roles as Substrate Receptors for CUL4-RING E3 Ubiquitin Ligases.
J.-H. Lee, W. Terzaghi, G. Gusmaroli, J.-B. F. Charron, H.-J. Yoon, H. Chen, Y. J. He, Y. Xiong, and X. W. Deng (2008)
PLANT CELL 20, 152-167
   Abstract »    Full Text »    PDF »
A yeast two-hybrid system reconstituting substrate recognition of the von Hippel-Lindau tumor suppressor protein.
C. Bex, K. Knauth, S. Dambacher, and A. Buchberger (2007)
Nucleic Acids Res. 35, e142
   Abstract »    Full Text »    PDF »
JAK kinases promote invasiveness in VHL-mediated renal cell carcinoma by a suppressor of cytokine signaling-regulated, HIF-independent mechanism.
K. L. Wu, H. Miao, and S. Khan (2007)
Am J Physiol Renal Physiol 293, F1836-F1846
   Abstract »    Full Text »    PDF »
Hypoxia-Inducible Factor Linked to Differential Kidney Cancer Risk Seen with Type 2A and Type 2B VHL Mutations.
L. Li, L. Zhang, X. Zhang, Q. Yan, Y. A. Minamishima, A. F. Olumi, M. Mao, S. Bartz, and W. G. Kaelin Jr. (2007)
Mol. Cell. Biol. 27, 5381-5392
   Abstract »    Full Text »    PDF »
Adenovirus E4orf6 assembles with Cullin5-ElonginB-ElonginC E3 ubiquitin ligase through an HIV/SIV Vif-like BC-box to regulate p53.
K. Luo, E. Ehrlich, Z. Xiao, W. Zhang, G. Ketner, and X.-F. Yu (2007)
FASEB J 21, 1742-1750
   Abstract »    Full Text »    PDF »
Hypoxia-inducible Expression of a Natural cis-Antisense Transcript Inhibits Endothelial Nitric-oxide Synthase.
J. E. Fish, C. C. Matouk, E. Yeboah, S. C. Bevan, M. Khan, K. Patil, M. Ohh, and P. A. Marsden (2007)
J. Biol. Chem. 282, 15652-15666
   Abstract »    Full Text »    PDF »
EGLN3 Prolyl Hydroxylase Regulates Skeletal Muscle Differentiation and Myogenin Protein Stability.
J. Fu, K. Menzies, R. S. Freeman, and M. B. Taubman (2007)
J. Biol. Chem. 282, 12410-12418
   Abstract »    Full Text »    PDF »
Molecular Biology of Renal Cell Cancer and the Identification of Therapeutic Targets.
O. Iliopoulos (2006)
J. Clin. Oncol. 24, 5593-5600
   Abstract »    Full Text »    PDF »
Role of hypoxia-inducible factor-1{alpha} as a cancer therapy target.
S. Patiar and A. L Harris (2006)
Endocr. Relat. Cancer 13, S61-S75
   Abstract »    Full Text »    PDF »
DDB1 functions as a linker to recruit receptor WD40 proteins to CUL4-ROC1 ubiquitin ligases..
Y. J. He, C. M. McCall, J. Hu, Y. Zeng, and Y. Xiong (2006)
Genes & Dev. 20, 2949-2954
   Abstract »    Full Text »    PDF »
Constitutive and UV-induced Fibronectin Degradation Is a Ubiquitination-dependent Process Controlled by beta-TrCP.
D. Ray, E. C. Osmundson, and H. Kiyokawa (2006)
J. Biol. Chem. 281, 23060-23065
   Abstract »    Full Text »    PDF »
Priming-Dependent Phosphorylation and Regulation of the Tumor Suppressor pVHL by Glycogen Synthase Kinase 3.
A. Hergovich, J. Lisztwan, C. R. Thoma, C. Wirbelauer, R. E. Barry, and W. Krek (2006)
Mol. Cell. Biol. 26, 5784-5796
   Abstract »    Full Text »    PDF »
Should Patients with Apparently Sporadic Pheochromocytomas or Paragangliomas be Screened for Hereditary Syndromes?.
C. Jimenez, G. Cote, A. Arnold, and R. F. Gagel (2006)
J. Clin. Endocrinol. Metab. 91, 2851-2858
   Abstract »    Full Text »    PDF »
Von Hippel-Lindau disease and endocrine tumour susceptibility..
E. R Woodward and E. R Maher (2006)
Endocr. Relat. Cancer 13, 415-425
   Abstract »    Full Text »    PDF »
Crystal structure of the SOCS2-elongin C-elongin B complex defines a prototypical SOCS box ubiquitin ligase.
A. N. Bullock, J. E. Debreczeni, A. M. Edwards, M. Sundstrom, and S. Knapp (2006)
PNAS 103, 7637-7642
   Abstract »    Full Text »    PDF »
Histone Deacetylase Inhibitors Repress the Transactivation Potential of Hypoxia-inducible Factors Independently of Direct Acetylation of HIF-{alpha}.
D. M. Fath, X. Kong, D. Liang, Z. Lin, A. Chou, Y. Jiang, J. Fang, J. Caro, and N. Sang (2006)
J. Biol. Chem. 281, 13612-13619
   Abstract »    Full Text »    PDF »
pVHL Function Is Essential for Endothelial Extracellular Matrix Deposition..
N. Tang, F. Mack, V. H. Haase, M. C. Simon, and R. S. Johnson (2006)
Mol. Cell. Biol. 26, 2519-2530
   Abstract »    Full Text »    PDF »
Degrade to create: developmental requirements for ubiquitin-mediated proteolysis during early C. elegans embryogenesis.
B. Bowerman and T. Kurz (2006)
Development 133, 773-784
   Abstract »    Full Text »    PDF »
Negative Regulation of Growth Hormone Receptor Signaling.
A. Flores-Morales, C. J. Greenhalgh, G. Norstedt, and E. Rico-Bautista (2006)
Mol. Endocrinol. 20, 241-253
   Abstract »    Full Text »    PDF »
From the Cover: Mouse model for noninvasive imaging of HIF prolyl hydroxylase activity: Assessment of an oral agent that stimulates erythropoietin production.
M. Safran, W. Y. Kim, F. O'Connell, L. Flippin, V. Gunzler, J. W. Horner, R. A. DePinho, and W. G. Kaelin Jr. (2006)
PNAS 103, 105-110
   Abstract »    Full Text »    PDF »
Cullin3 Is a KLHL10-Interacting Protein Preferentially Expressed During Late Spermiogenesis.
S. Wang, H. Zheng, Y. Esaki, F. Kelly, and W. Yan (2006)
Biol Reprod 74, 102-108
   Abstract »    Full Text »    PDF »
Primate lentiviral virion infectivity factors are substrate receptors that assemble with cullin 5-E3 ligase through a HCCH motif to suppress APOBEC3G.
K. Luo, Z. Xiao, E. Ehrlich, Y. Yu, B. Liu, S. Zheng, and X.-F. Yu (2005)
PNAS 102, 11444-11449
   Abstract »    Full Text »    PDF »
Ankyrin Repeat and SOCS Box 3 (ASB3) Mediates Ubiquitination and Degradation of Tumor Necrosis Factor Receptor II.
A. S. Chung, Y.-j. Guan, Z.-L. Yuan, J. E. Albina, and Y. E. Chin (2005)
Mol. Cell. Biol. 25, 4716-4726
   Abstract »    Full Text »    PDF »
Cullins 3a and 3b Assemble with Members of the Broad Complex/Tramtrack/Bric-a-Brac (BTB) Protein Family to Form Essential Ubiquitin-Protein Ligases (E3s) in Arabidopsis.
D. J. Gingerich, J. M. Gagne, D. W. Salter, H. Hellmann, M. Estelle, L. Ma, and R. D. Vierstra (2005)
J. Biol. Chem. 280, 18810-18821
   Abstract »    Full Text »    PDF »
Arabidopsis Has Two Redundant Cullin3 Proteins That Are Essential for Embryo Development and That Interact with RBX1 and BTB Proteins to Form Multisubunit E3 Ubiquitin Ligase Complexes in Vivo.
P. Figueroa, G. Gusmaroli, G. Serino, J. Habashi, L. Ma, Y. Shen, S. Feng, M. Bostick, J. Callis, H. Hellmann, et al. (2005)
PLANT CELL 17, 1180-1195
   Abstract »    Full Text »    PDF »
Inactivation of VHL by Tumorigenic Mutations That Disrupt Dynamic Coupling of the pVHL{middle dot}Hypoxia-inducible Transcription Factor-1{alpha} Complex.
F. Miller, A. Kentsis, R. Osman, and Z.-Q. Pan (2005)
J. Biol. Chem. 280, 7985-7996
   Abstract »    Full Text »    PDF »
ASB2 Is an Elongin BC-interacting Protein That Can Assemble with Cullin 5 and Rbx1 to Reconstitute an E3 Ubiquitin Ligase Complex.
M. L. Heuze, F. C. Guibal, C. A. Banks, J. W. Conaway, R. C. Conaway, Y. E. Cayre, A. Benecke, and P. G. Lutz (2005)
J. Biol. Chem. 280, 5468-5474
   Abstract »    Full Text »    PDF »
BTB Protein Keap1 Targets Antioxidant Transcription Factor Nrf2 for Ubiquitination by the Cullin 3-Roc1 Ligase.
M. Furukawa and Y. Xiong (2005)
Mol. Cell. Biol. 25, 162-171
   Abstract »    Full Text »    PDF »
Role of VHL Gene Mutation in Human Cancer.
W. Y. Kim and W. G. Kaelin (2004)
J. Clin. Oncol. 22, 4991-5004
   Abstract »    Full Text »    PDF »
VHL-box and SOCS-box domains determine binding specificity for Cul2-Rbx1 and Cul5-Rbx2 modules of ubiquitin ligases.
T. Kamura, K. Maenaka, S. Kotoshiba, M. Matsumoto, D. Kohda, R. C. Conaway, J. W. Conaway, and K. I. Nakayama (2004)
Genes & Dev. 18, 3055-3065
   Abstract »    Full Text »    PDF »
Phosphorylation of a novel SOCS-box regulates assembly of the HIV-1 Vif-Cul5 complex that promotes APOBEC3G degradation.
A. Mehle, J. Goncalves, M. Santa-Marta, M. McPike, and D. Gabuzda (2004)
Genes & Dev. 18, 2861-2866
   Abstract »    Full Text »    PDF »
Solution Structure of a Ubiquitin-like Domain from Tubulin-binding Cofactor B.
B. L. Lytle, F. C. Peterson, S.-H. Qiu, M. Luo, Q. Zhao, J. L. Markley, and B. F. Volkman (2004)
J. Biol. Chem. 279, 46787-46793
   Abstract »    Full Text »    PDF »
Both BC-Box Motifs of Adenovirus Protein E4orf6 Are Required To Efficiently Assemble an E3 Ligase Complex That Degrades p53.
P. Blanchette, C. Y. Cheng, Q. Yan, G. Ketner, D. A. Ornelles, T. Dobner, R. C. Conaway, J. W. Conaway, and P. E. Branton (2004)
Mol. Cell. Biol. 24, 9619-9629
   Abstract »    Full Text »    PDF »
Identification of Elongin C and Skp1 Sequences That Determine Cullin Selection.
Q. Yan, T. Kamura, Y. Cai, J. Jin, M. Ivan, A. Mushegian, R. C. Conaway, and J. W. Conaway (2004)
J. Biol. Chem. 279, 43019-43026
   Abstract »    Full Text »    PDF »
A Facile Method for High-throughput Co-expression of Protein Pairs.
A. Alexandrov, M. Vignali, D. J. LaCount, E. Quartley, C. de Vries, D. De Rosa, J. Babulski, S. F. Mitchell, L. W. Schoenfeld, S. Fields, et al. (2004)
Mol. Cell. Proteomics 3, 934-938
   Abstract »    Full Text »    PDF »
The role of von Hippel-Lindau tumor suppressor protein and hypoxia in renal clear cell carcinoma.
R. I. Sufan, M. A. S. Jewett, and M. Ohh (2004)
Am J Physiol Renal Physiol 287, F1-F6
   Abstract »    Full Text »    PDF »
Oxygen-dependent and tissue-specific regulation of erythropoietin gene expression.
J. Fandrey (2004)
Am J Physiol Regulatory Integrative Comp Physiol 286, R977-R988
   Abstract »    Full Text »    PDF »
The von Hippel-Lindau Tumor Suppressor Protein Is a Molten Globule under Native Conditions: IMPLICATIONS FOR ITS PHYSIOLOGICAL ACTIVITIES.
H. Sutovsky and E. Gazit (2004)
J. Biol. Chem. 279, 17190-17196
   Abstract »    Full Text »    PDF »
pVHL Modification by NEDD8 Is Required for Fibronectin Matrix Assembly and Suppression of Tumor Development.
N. H. Stickle, J. Chung, J. M. Klco, R. P. Hill, W. G. Kaelin Jr., and M. Ohh (2004)
Mol. Cell. Biol. 24, 3251-3261
   Abstract »    Full Text »    PDF »
Combination of multiple alignment analysis and surface mapping paves a way for a detailed pathway reconstruction--The case of VHL (von Hippel-Lindau) protein and angiogenesis regulatory pathway.
S. Sikora and A. Godzik (2004)
Protein Sci. 13, 786-796
   Abstract »    Full Text »    PDF »
Tumor Suppressor von Hippel-Lindau (VHL) Stabilization of Jade-1 Protein Occurs through Plant Homeodomains and Is VHL Mutation Dependent.
M. I. Zhou, H. Wang, R. L. Foy, J. J. Ross, and H. T. Cohen (2004)
Cancer Res. 64, 1278-1286
   Abstract »    Full Text »    PDF »
Inhibition of Hypoxia-Inducible Factor Is Sufficient for Growth Suppression of VHL-/- Tumors.
M. Zimmer, D. Doucette, N. Siddiqui, and O. Iliopoulos (2004)
Mol. Cancer Res. 2, 89-95
   Abstract »    Full Text »    PDF »
Molecular Cloning and Characterization of the von Hippel-Lindau-Like Protein.
H. Qi, M. L. Gervais, W. Li, J. A. DeCaprio, J. R.G. Challis, and M. Ohh (2004)
Mol. Cancer Res. 2, 43-52
   Abstract »    Full Text »    PDF »
Induction of APOBEC3G Ubiquitination and Degradation by an HIV-1 Vif-Cul5-SCF Complex.
X. Yu, Y. Yu, B. Liu, K. Luo, W. Kong, P. Mao, and X.-F. Yu (2003)
Science 302, 1056-1060
   Abstract »    Full Text »    PDF »
The von Hippel-Lindau Gene, Kidney Cancer, and Oxygen Sensing.
W. G. Kaelin Jr. (2003)
J. Am. Soc. Nephrol. 14, 2703-2711
   Abstract »    Full Text »    PDF »
Angiogenesis in Endocrine Tumors.
H. E. Turner, A. L. Harris, S. Melmed, and J. A. H. Wass (2003)
Endocr. Rev. 24, 600-632
   Abstract »    Full Text »    PDF »
Hepatic Vascular Tumors, Angiectasis in Multiple Organs, and Impaired Spermatogenesis in Mice with Conditional Inactivation of the VHL Gene.
W. Ma, L. Tessarollo, S.-B. Hong, M. Baba, E. Southon, T. C. Back, S. Spence, C. G. Lobe, N. Sharma, G. W. Maher, et al. (2003)
Cancer Res. 63, 5320-5328
   Abstract »    Full Text »    PDF »
Tyrosine Phosphorylation Disrupts Elongin Interaction and Accelerates SOCS3 Degradation.
S. Haan, P. Ferguson, U. Sommer, M. Hiremath, D. W. McVicar, P. C. Heinrich, J. A. Johnston, and N. A. Cacalano (2003)
J. Biol. Chem. 278, 31972-31979
   Abstract »    Full Text »    PDF »
Pheochromocytoma: The Expanding Genetic Differential Diagnosis.
J. Bryant, J. Farmer, L. J. Kessler, R. R. Townsend, and K. L. Nathanson (2003)
J Natl Cancer Inst 95, 1196-1204
   Abstract »    Full Text »    PDF »
A Role for Saccharomyces cerevisiae Cul8 Ubiquitin Ligase in Proper Anaphase Progression.
J. J. Michel, J. F. McCarville, and Y. Xiong (2003)
J. Biol. Chem. 278, 22828-22837
   Abstract »    Full Text »    PDF »
GABARAP: Lessons for Synaptogenesis.
J. E. Coyle and D. B. Nikolov (2003)
Neuroscientist 9, 205-216
   Abstract »    PDF »
Multiple Splice Variants of the Human HIF-3alpha Locus Are Targets of the von Hippel-Lindau E3 Ubiquitin Ligase Complex.
M. A. Maynard, H. Qi, J. Chung, E. H. L. Lee, Y. Kondo, S. Hara, R. C. Conaway, J. W. Conaway, and M. Ohh (2003)
J. Biol. Chem. 278, 11032-11040
   Abstract »    Full Text »    PDF »
Pheochromocytoma in Von Hippel-Lindau Disease.
F. J. Hes, J. W. M. Hoppener, and C. J. M. Lips (2003)
J. Clin. Endocrinol. Metab. 88, 969-974
   Full Text »    PDF »
High frequency of novel germline mutations in the VHL gene in the heterogeneous population of Brazil.
J C C Rocha, R L A Silva, B B Mendonca, S Marui, A J G Simpson, and A A Camargo (2003)
J. Med. Genet. 40, e31-31
   Full Text »    PDF »
Characterization of the Last Subunit of the Arabidopsis COP9 Signalosome: Implications for the Overall Structure and Origin of the Complex.
G. Serino, H. Su, Z. Peng, T. Tsuge, N. Wei, H. Gu, and X. W. Deng (2003)
PLANT CELL 15, 719-731
   Abstract »    Full Text »    PDF »
Identification of Residues Critical for Regulation of Protein Stability and the Transactivation Function of the Hypoxia-inducible Factor-1alpha by the von Hippel-Lindau Tumor Suppressor Gene Product.
T. Pereira, X. Zheng, J. L. Ruas, K. Tanimoto, and L. Poellinger (2003)
J. Biol. Chem. 278, 6816-6823
   Abstract »    Full Text »    PDF »
A three-dimensional model of Suppressor Of Cytokine Signalling 1 (SOCS-1).
F. Giordanetto and R. T. Kroemer (2003)
Protein Eng. Des. Sel. 16, 115-124
   Abstract »    Full Text »    PDF »
Structure of factor-inhibiting hypoxia-inducible factor 1: An asparaginyl hydroxylase involved in the hypoxic response pathway.
C. E. Dann III, R. K. Bruick, and J. Deisenhofer (2002)
PNAS 99, 15351-15356
   Abstract »    Full Text »    PDF »
VHL2C Phenotype in a German von Hippel-Lindau Family with Concurrent VHL Germline Mutations P81S and L188V.
G. Weirich, B. Klein, T. Wohl, D. Engelhardt, and H. Brauch (2002)
J. Clin. Endocrinol. Metab. 87, 5241-5246
   Abstract »    Full Text »    PDF »
Leu-574 of HIF-1alpha Is Essential for the von Hippel-Lindau (VHL)-mediated Degradation Pathway.
L. E. Huang, E. A. Pete, M. Schau, J. Milligan, and J. Gu (2002)
J. Biol. Chem. 277, 41750-41755
   Abstract »    Full Text »    PDF »
VHL Tumor Suppressor Gene Alterations Associated With Good Prognosis in Sporadic Clear-Cell Renal Carcinoma.
M. Yao, M. Yoshida, T. Kishida, N. Nakaigawa, M. Baba, K. Kobayashi, T. Miura, M. Moriyama, Y. Nagashima, Y. Nakatani, et al. (2002)
J Natl Cancer Inst 94, 1569-1575
   Abstract »    Full Text »    PDF »
Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor.
M. Ivan, T. Haberberger, D. C. Gervasi, K. S. Michelson, V. Gunzler, K. Kondo, H. Yang, I. Sorokina, R. C. Conaway, J. W. Conaway, et al. (2002)
PNAS 99, 13459-13464
   Abstract »    Full Text »    PDF »
The pressure rises: update on the genetics of phaeochromocytoma.
E. R. Maher and C. Eng (2002)
Hum. Mol. Genet. 11, 2347-2354
   Abstract »    Full Text »    PDF »
Analysis of the Adenovirus E1B-55K-Anchored Proteome Reveals Its Link to Ubiquitination Machinery.
J. N. Harada, A. Shevchenko, A. Shevchenko, D. C. Pallas, and A. J. Berk (2002)
J. Virol. 76, 9194-9206
   Abstract »    Full Text »    PDF »
A Molecular Basis for Stabilization of the von Hippel-Lindau (VHL) Tumor Suppressor Protein by Components of the VHL Ubiquitin Ligase.
T. Kamura, C. S. Brower, R. C. Conaway, and J. W. Conaway (2002)
J. Biol. Chem. 277, 30388-30393
   Abstract »    Full Text »    PDF »
Mammalian mediator subunit mMED8 is an Elongin BC-interacting protein that can assemble with Cul2 and Rbx1 to reconstitute a ubiquitin ligase.
C. S. Brower, S. Sato, C. Tomomori-Sato, T. Kamura, A. Pause, R. Stearman, R. D. Klausner, S. Malik, W. S. Lane, I. Sorokina, et al. (2002)
PNAS 99, 10353-10358
   Abstract »    Full Text »    PDF »
Oxygen-Dependent Ubiquitination and Degradation of Hypoxia-Inducible Factor Requires Nuclear-Cytoplasmic Trafficking of the von Hippel-Lindau Tumor Suppressor Protein.
I. Groulx and S. Lee (2002)
Mol. Cell. Biol. 22, 5319-5336
   Abstract »    Full Text »    PDF »
CUL-4A Is Critical for Early Embryonic Development.
B. Li, J. C. Ruiz, and K. T. Chun (2002)
Mol. Cell. Biol. 22, 4997-5005
   Abstract »    Full Text »    PDF »
Genetic and functional analysis of the von Hippel-Lindau (VHL) tumour suppressor gene promoter.
M Zatyka, C Morrissey, I Kuzmin, M I Lerman, F Latif, F M Richards, and E R Maher (2002)
J. Med. Genet. 39, 463-472
   Abstract »    Full Text »    PDF »
Association of the P-Glycoprotein Transporter MDR1C3435T Polymorphism with the Susceptibility to Renal Epithelial Tumors.
M. Siegsmund, U. Brinkmann, E. Schaffeler, G. Weirich, M. Schwab, M. Eichelbaum, P. Fritz, O. Burk, J. Decker, P. Alken, et al. (2002)
J. Am. Soc. Nephrol. 13, 1847-1854
   Abstract »    Full Text »    PDF »
Structure of an HIF-1alpha -pVHL Complex: Hydroxyproline Recognition in Signaling.
J.-H. Min, H. Yang, M. Ivan, F. Gertler, W. G. Kaelin Jr., and N. P. Pavletich (2002)
Science 296, 1886-1889
   Abstract »    Full Text »    PDF »
Paraneoplastic erythrocytosis associated with an inactivating point mutation of the von Hippel-Lindau gene in a renal cell carcinoma.
M. S. Wiesener, M. Seyfarth, C. Warnecke, J. S. Jurgensen, C. Rosenberger, N. V. Morgan, E. R. Maher, U. Frei, and K.-U. Eckardt (2002)
Blood 99, 3562-3565
   Abstract »    Full Text »    PDF »
Carboxyl-Terminal Transactivation Activity of Hypoxia-Inducible Factor 1{alpha} Is Governed by a von Hippel-Lindau Protein-Independent, Hydroxylation-Regulated Association with p300/CBP.
N. Sang, J. Fang, V. Srinivas, I. Leshchinsky, and J. Caro (2002)
Mol. Cell. Biol. 22, 2984-2992
   Abstract »    Full Text »    PDF »
Low mitochondrial respiratory chain content correlates with tumor aggressiveness in renal cell carcinoma.
H. Simonnet, N. Alazard, K. Pfeiffer, C. Gallou, C. Beroud, J. Demont, R. Bouvier, H. Schagger, and C. Godinot (2002)
Carcinogenesis 23, 759-768
   Abstract »    Full Text »    PDF »
Role of the von Hippel-Lindau Tumor Suppressor Gene in the Formation of {beta}1-Integrin Fibrillar Adhesions.
M. A. Esteban-Barragan, P. Avila, M. Alvarez-Tejado, M. D. Gutierrez, A. Garcia-Pardo, F. Sanchez-Madrid, and M. O. Landazuri (2002)
Cancer Res. 62, 2929-2936
   Abstract »    Full Text »    PDF »
Diverse Effects of Mutations in Exon II of the von Hippel-Lindau (VHL) Tumor Suppressor Gene on the Interaction of pVHL with the Cytosolic Chaperonin and pVHL-Dependent Ubiquitin Ligase Activity.
W. J. Hansen, M. Ohh, J. Moslehi, K. Kondo, W. G. Kaelin, and W. J. Welch (2002)
Mol. Cell. Biol. 22, 1947-1960
   Abstract »    Full Text »    PDF »
Erythropoietin, tumours and the von Hippel-Lindau gene: towards identification of mechanisms and dysfunction of oxygen sensing.
M. S. Wiesener and K.-U. Eckardt (2002)
Nephrol. Dial. Transplant. 17, 356-359
   Full Text »    PDF »
Degradation of p53 by adenovirus E4orf6 and E1B55K proteins occurs via a novel mechanism involving a Cullin-containing complex.
E. Querido, P. Blanchette, Q. Yan, T. Kamura, M. Morrison, D. Boivin, W. G. Kaelin, R. C. Conaway, J. W. Conaway, and P. E. Branton (2001)
Genes & Dev. 15, 3104-3117
   Abstract »    Full Text »    PDF »
The von Hippel-Lindau Tumor Suppressor Protein Mediates Ubiquitination of Activated Atypical Protein Kinase C.
H. Okuda, K. Saitoh, S.-i. Hirai, K. Iwai, Y. Takaki, M. Baba, N. Minato, S. Ohno, and T. Shuin (2001)
J. Biol. Chem. 276, 43611-43617
   Abstract »    Full Text »    PDF »
The Von Hippel-Lindau Protein Interacts with Heteronuclear Ribonucleoprotein A2 and Regulates Its Expression.
P. A. Pioli and W. F. C. Rigby (2001)
J. Biol. Chem. 276, 40346-40352
   Abstract »    Full Text »    PDF »
Endoplasmic Reticulum Stress Prolongs GH-Induced Janus Kinase (JAK2)/Signal Transducer and Activator of Transcription (STAT5) Signaling Pathway.
A. Flores-Morales, L. Fernandez, E. Rico-Bautista, A. Umana, C. Negrin, J.-G. Zhang, and G. Norstedt (2001)
Mol. Endocrinol. 15, 1471-1483
   Abstract »    Full Text »    PDF »
Molecular Pathogenesis of the Von Hippel-Lindau Hereditary Cancer Syndrome: Implications for Oxygen Sensing.
H. Yang and W. G. Kaelin Jr. (2001)
Cell Growth Differ. 12, 447-455